COSCIENS Biopharma Inc. (TSX:CSCI)
Canada · Delayed Price · Currency is CAD 3.240
+0.240 (8.00%)
Jun 30, 2026, 3:16 PM EST
COSCIENS Biopharma Earnings Call Transcripts
Fiscal Year 2026
-
The meeting covered board elections, auditor appointment, and approval of a share consolidation and split. Management addressed a shareholder question on strategic focus, confirming ongoing cost management and prioritization of PGX. All motions were approved.
Fiscal Year 2024
-
The meeting covered board elections, auditor appointment, and approval of a corporate name change. Six directors were elected, one did not receive a majority but remains temporarily, and all resolutions passed. No shareholder questions were submitted.